发明名称 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals.
摘要 <p>Compounds of formula I, &lt;CHEM&gt; wherein A represents C=C, S or O; Q represents a 5- or 6-membered unsaturated heterocyclic ring having a nitrogen atom in the position adjacent to the point of attachment, 0-3 further heteroatoms selected from N, O and S, and substituents R6 and R7; R&lt;1&gt; represents H or C&lt;5&gt; PI 1/4 alkyl; R&lt;2&gt; represents H, C&lt;5&gt; PI 1/4 alkyl, C&lt;7&gt; PI 1/4 alkenyl, C&lt;7&gt; PI 1/4 alkynyl, C&lt;7&gt; PI 1/4 cycloalkyl or NH&lt;6&gt;CH&lt;6&gt;CO-; in addition, R&lt;1&gt; and R&lt;2&gt; taken together may form a C&lt;7&gt; PI psi alkylene chain; R&lt;3&gt; represents H, C&lt;5&gt; PI 1/4 alkyl, C&lt;7&gt; PI 1/4 alkenyl, C&lt;7&gt; PI 1/4 alkynyl; R4 and R5 independently represent H, OH, C&lt;5&gt; PI 1/4 alkoxy, C&lt;5&gt; PI 1/4 alkyl, halogen, trifluoromethyl or NR8R9; R6 and R7 independently represent H, OH, C&lt;5&gt; PI 1/4 alkoxy, C&lt;5&gt; PI 1/4 alkyl, halogen, trifluoromethyl, C&lt;5&gt; PI 1/4 hydroxyalkyl, amidino, CONH&lt;6&gt; or NR8R9; in addition, R6 and R7 may independently represent O when substituted on N; R8 and R9 independently represent H or C&lt;5&gt; PI 1/4 alkyl; with various provisos; and pharmaceutically acceptable derivatives thereof; are useful as pharmaceuticals, in particular in the treatment of neurological disorders.</p>
申请公布号 EP0540318(A1) 申请公布日期 1993.05.05
申请号 EP19920309888 申请日期 1992.10.28
申请人 FISONS CORPORATION 发明人 GRIFFITH, RONALD CONRAD;MURRAY, ROBERT JOHN;SCHMIESING, RICHARD JON
分类号 A61K31/415;A61K31/42;A61K31/421;A61K31/425;A61K31/426;A61K31/433;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/496;A61K31/4965;A61K31/497;A61K31/54;A61P9/10;A61P25/30;A61P25/00;A61P25/08;A61P25/16;C07D207/00;C07D213/36;C07D213/38;C07D213/40;C07D213/61;C07D213/73;C07D213/81;C07D213/89;C07D231/12;C07D233/54;C07D233/64;C07D237/08;C07D239/26;C07D241/12;C07D241/16;C07D249/08;C07D261/08;C07D263/32;C07D277/22;C07D285/08;C07D401/06;C07D405/06;C07D409/06;C07D417/06 主分类号 A61K31/415
代理机构 代理人
主权项
地址